TTM
$5.54B
YoY change
+9.8%
5Y CAGR
+11.7%
Peak year (2025)
$5.15B
Cumulative revenue
$50.16B
Revenue history chart for ResMed (RMD) from 1993 to 2025
Latest: $5.15B
Revenue growth chart for ResMed (RMD) from 1993 to 2025
Latest: +9.8%
Revenue history table for ResMed (RMD) from 1993 to 2025
| 2025 | $5.15B | +9.8% | +$461.03M | ||
| 2024 | $4.69B | +10.9% | +$462.30M | ||
| 2023 | $4.22B | +18.0% | +$644.87M | ||
| 2022 | $3.58B | +11.9% | +$381.30M | ||
| 2021 | $3.20B | +8.1% | +$239.81M | ||
| 2020 | $2.96B | +13.4% | +$350.44M | ||
| 2019 | $2.61B | +11.4% | +$266.38M | ||
| 2018 | $2.34B | +13.2% | +$273.46M | ||
| 2017 | $2.07B | +12.4% | +$228.02M | ||
| 2016 | $1.84B | +9.5% | +$159.80M | ||
| 2015 | $1.68B | +8.0% | +$123.94M | ||
| 2014 | $1.55B | +2.7% | +$40.52M | ||
| 2013 | $1.51B | +10.7% | +$145.94M | ||
| 2012 | $1.37B | +10.1% | +$125.37M | ||
| 2011 | $1.24B | +13.8% | +$150.79M | ||
| 2010 | $1.09B | +18.6% | +$171.62M | ||
| 2009 | $920.74M | +10.2% | +$85.34M | ||
| 2008 | $835.40M | +16.6% | +$119.06M | ||
| 2007 | $716.33M | +18.0% | +$109.34M | ||
| 2006 | $607.00M | +42.7% | +$181.49M | ||
| 2005 | $425.50M | +25.4% | +$86.17M | ||
| 2004 | $339.34M | +24.0% | +$65.77M | ||
| 2003 | $273.57M | +34.1% | +$69.49M | ||
| 2002 | $204.08M | +31.5% | +$48.92M | ||
| 2001 | $155.16M | +34.2% | +$39.54M | ||
| 2000 | $115.61M | +30.5% | +$27.02M | ||
| 1999 | $88.60M | +33.2% | +$22.10M | ||
| 1998 | $66.50M | +35.2% | +$17.30M | ||
| 1997 | $49.20M | +42.2% | +$14.60M | ||
| 1996 | $34.60M | +47.2% | +$11.10M | ||
| 1995 | $23.50M | +69.1% | +$9.60M | ||
| 1994 | $13.90M | +80.5% | +$6.20M | ||
| 1993 | $7.70M | — | — |
- 2025$5.15B+9.8%
- 2024$4.69B+10.9%
- 2023$4.22B+18.0%
- 2022$3.58B+11.9%
- 2021$3.20B+8.1%
- 2020$2.96B+13.4%
- 2019$2.61B+11.4%
- 2018$2.34B+13.2%
- 2017$2.07B+12.4%
- 2016$1.84B+9.5%
- 2015$1.68B+8.0%
- 2014$1.55B+2.7%
- 2013$1.51B+10.7%
- 2012$1.37B+10.1%
- 2011$1.24B+13.8%
- 2010$1.09B+18.6%
- 2009$920.74M+10.2%
- 2008$835.40M+16.6%
- 2007$716.33M+18.0%
- 2006$607.00M+42.7%
- 2005$425.50M+25.4%
- 2004$339.34M+24.0%
- 2003$273.57M+34.1%
- 2002$204.08M+31.5%
- 2001$155.16M+34.2%
- 2000$115.61M+30.5%
- 1999$88.60M+33.2%
- 1998$66.50M+35.2%
- 1997$49.20M+42.2%
- 1996$34.60M+47.2%
- 1995$23.50M+69.1%
- 1994$13.90M+80.5%
- 1993$7.70M—
Revenue values are taken from ResMed's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Revenue at ResMed (RMD)
According to ResMed's latest reported financial statements, the company's current revenue (TTM) is $5.54B. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, ResMed (RMD) reported revenue of $5.15B – grew 9.8% year-over-year.
ResMed revenue has grown for 32 consecutive years, with a +11.7% compound annual growth rate over 2020–2025 (5 years).
$5.15B stands as the all-time-high annual revenue, posted in 2025, against a low of $7.70M during 1993.
ResMed Revenue by Year
ResMed Revenue 2025: $5.15B
In 2025, ResMed reported revenue of $5.15B, grew 9.8% from 2024. This figure represents the highest annual value in the available history.
ResMed Revenue 2024: $4.69B
ResMed revenue in 2024 was $4.69B, grew 10.9% from 2023.
ResMed Revenue 2023: $4.22B
2023's revenue for ResMed came in at $4.22B, grew 18.0% from 2022.
ResMed Revenue 2022: $3.58B
ResMed posted revenue of $3.58B in 2022, grew 11.9% from 2021.
ResMed Revenue 2021: $3.20B
ResMed revenue in 2021 was $3.20B.
See more financial history for ResMed (RMD).
Sector peers by Revenue
Healthcare peers of ResMed (RMD), ranked by their latest revenue
| $447.57B | |
| $94.19B | |
| $65.18B | |
| $64.93B | |
| $61.16B | |
| $58.74B | |
| $48.18B | |
| $36.74B |
- $447.57B
- $94.19B
- $65.18B
- $64.93B
- $61.16B
- $58.74B
- $48.18B
- $36.74B
Frequently asked questions
ResMed (RMD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation